Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial

BACKGROUND: FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas neoadjuvant chemoradiotherapy (CROSS) achieves good locoregional response with clinically complete response (cCR) rates up to 33% [1]. T...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zijden, Charlène J., Eyck, Ben M., van der Gaast, Ate, van Doorn, Leni, Nuyttens, Joost J.M.E., van Lanschot, J. Jan B., Wijnhoven, Bas P.L., Mostert, Bianca, Lagarde, Sjoerd M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163410/
https://www.ncbi.nlm.nih.gov/pubmed/35669486
http://dx.doi.org/10.1016/j.conctc.2022.100934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163410/
https://www.ncbi.nlm.nih.gov/pubmed/35669486
http://dx.doi.org/10.1016/j.conctc.2022.100934

Ejemplares similares